By Alvin Philipose
Short answer
COVID-19 infection is clearly linked to higher rates of anxiety, depression, brain fog and other neuropsychiatric problems. Laboratory and tissue studies show the SARS-CoV-2 spike protein can disturb the blood-brain barrier, switch on inflammatory pathways and linger near the brain. What has not been shown is that spike protein, by itself, causes mental illness in people.
The most defensible position today: spike protein is a biologically credible contributor to post-COVID neuropsychiatric symptoms, not a proven sole cause.
Two competing explanations
Public discussion tends to fall into one of two camps. The first credits post-COVID mental health problems mainly to stress, isolation, grief, job loss and the strain of a long illness. The second credits them to direct biological injury from the virus, and increasingly to the spike protein specifically.
Both framings are too narrow on their own. The evidence supports psychosocial stress and biological mechanisms acting together, with spike protein as one plausible biological thread among several.
What population studies show
Large health-record studies consistently find more neurological and psychiatric diagnoses after COVID-19 than after comparison illnesses. A 2021 Lancet Psychiatry analysis of over 236,000 COVID-19 patients (Taquet et al.) reported that roughly one in three received a neurological or psychiatric diagnosis within six months. A 2022 BMJ study of US veterans (Xie, Xu and Al-Aly) found elevated risks of anxiety, depression, sleep disorders and cognitive decline in the year after infection.
These studies establish association, not mechanism. Infection brings fever, immune activation, low oxygen, hospitalization, medications, lost income and isolation all at once. Health-record data cannot separate spike protein from any of these exposures.
Proposed spike protein mechanisms
Four lines of experimental work point to ways spike protein could affect the brain. Each was shown in cells, animal models or post-mortem tissue, not in controlled human trials.
| Mechanism | Key study | Model | What it suggests |
|---|---|---|---|
| Blood-brain barrier disruption | DeOre et al., 2021 | 3D human blood-brain barrier model | Spike activated RhoA, a regulator of tight junctions, loosening the barrier |
| Inflammasome activation | Theobald et al., 2021, and follow-up work | Immune cells and microglia | Spike can prime or trigger the NLRP3 inflammasome, a driver of neuroinflammation |
| Persistence near the brain | Rong et al., 2024, Cell Host & Microbe | Mouse models and human post-mortem tissue | Spike was detected in skull marrow, meninges and brain tissue long after infection |
| Neurotransmitter enzyme interaction | 2023 cellular study | Cell systems | Spike interacted with MAO-B, an enzyme that breaks down dopamine |
Taken together, these findings make a biological role for spike protein plausible. They do not show how much spike reaches the human brain, how long it stays, or whether it changes mood or behavior at real-world levels.
What has not been demonstrated
Several gaps separate the lab findings from a causal claim about mental illness in people:
- Dose: many cell studies use spike concentrations that may exceed what circulates in patients.
- Isolation: no human study has separated spike protein from whole-virus infection, immune response and psychosocial stress.
- Causation: finding spike in brain tissue shows presence, not that it produced a specific symptom.
- Source: infection-derived and vaccine-derived spike differ in amount, duration and context; evidence for one does not transfer automatically to the other.
Treating spike as the established cause of long-COVID mental illness skips over these unresolved questions. Dismissing it entirely ignores a growing body of mechanistic data.
What this means for people with long COVID
If mood, anxiety, sleep or thinking changed after COVID-19, those symptoms are real and have a plausible biological basis. They are not simply “in your head,” and they are also not likely to have a single cause.
A practical approach looks at the whole picture: immune and inflammatory markers, autonomic function (as in POTS or dysautonomia), sleep, nutrition, and the psychological load of a long illness. Mental health support remains important even when a biological driver is suspected. Learn more about long COVID in Oklahoma City.
This article is educational and is not medical advice. Talk with a qualified clinician about your own symptoms.
Frequently asked questions
Can COVID-19 cause depression or anxiety?
COVID-19 is associated with higher rates of depression and anxiety in the months after infection. Biological and psychosocial factors likely both contribute.
Does the spike protein affect the brain?
Lab and tissue studies show spike protein can disrupt the blood-brain barrier, activate inflammation and persist near the brain. Its direct effect on human mental health is not yet proven.
Can spike protein cross the blood-brain barrier?
Animal studies indicate parts of the spike protein can cross it, and human barrier models show spike can weaken it.
How long does spike protein stay in the body after COVID?
Post-mortem and animal research has found spike in skull marrow and meninges long after infection. How common and how long this persistence is in living patients is still unknown.
Is brain fog after COVID caused by spike protein?
Spike protein is one plausible contributor. Inflammation, autonomic dysfunction, poor sleep and low oxygen during illness are other likely factors.
Sources
Adapted and summarized from SARS-CoV-2 Spike Protein and Mental Health: What Has Actually Been Demonstrated? (Popular Rationalism, Sept 2026).
- Taquet M, et al. Six-month neurological and psychiatric outcomes in 236,379 survivors of COVID-19. Lancet Psychiatry, 2021.
- Xie Y, Xu E, Al-Aly Z. Risks of mental health outcomes in people with COVID-19. BMJ, 2022.
- DeOre BJ, et al. SARS-CoV-2 spike protein disrupts blood-brain barrier integrity via RhoA activation. J Neuroimmune Pharmacol, 2021.
- Theobald SJ, et al. Long-lived macrophage reprogramming drives spike protein-mediated inflammasome activation in COVID-19. EMBO Mol Med, 2021.
- Rong Z, et al. Persistence of spike protein at the skull-meninges-brain axis may contribute to the neurological sequelae of COVID-19. Cell Host & Microbe, 2024.
